Daily intake of the antioxidant vitamin E is associated with a delay in the progression of coronary atherosclerosis after CABG and a reduction in the risk of restenosis post-PTCA, according to the findings of 2 new studies. Beneficial effects in slowing plaque build-up were noted even in patients not receiving cholesterol-lowering drugs. These encouraging results are further supported by a study reporting that low dietary vitamin E intake is related to an increased risk of CHD-related death in patients with no prior evidence of CHD who were controlled for common coronary risk factors. Larger studies are warranted to confirm the clinical benefit and optimal supplementary dose of this vitamin. The trial results were presented at the Second International Conference on Antioxidant Vitamins and Betacarotene in Disease Prevention [Berlin, Germany; October 1994].